[Federal Register Volume 82, Number 200 (Wednesday, October 18, 2017)]
[Notices]
[Pages 48521-48522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-22573]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-17-034: NIDDK 
Exploratory Clinical Trials in Small Business-Diabetics and its 
Complications.
    Date: November 13, 2017.
    Time: 1:00 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Najma S. Begum, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes Of Health, 
Room 7349, 6707 Democracy Boulevard, Bethesda, Md 20892-5452, (301) 
594-8894, <a href="/cdn-cgi/l/email-protection#8ae8efedffe7e4cae4e3eeeee1a4e4e3e2a4ede5fc"><span class="__cf_email__" data-cfemail="bbd9dedcced6d5fbd5d2dfdfd095d5d2d395dcd4cd">[email protected]</span></a>.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Cystic Fibrosis Clinical 
and Translation Centers.
    Date: December 4-5, 2017.
    Time: 8:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Ryan G. Morris, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes Of Health, 
Room 7015, 6707 Democracy Boulevard, Bethesda, Md 20892-2542, 301-
594-4721, <a href="/cdn-cgi/l/email-protection#106269717e3e7d7f62627963507e79783e777f66"><span class="__cf_email__" data-cfemail="6b19120a05450604191902182b050203450c041d">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research;

[[Page 48522]]

93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney 
Diseases, Urology and Hematology Research, National Institutes of 
Health, HHS)

    Dated: October 12, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-22573 Filed 10-17-17; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>